The Food and Drug Administration has granted approval for the first flu vaccine that uses mRNA technology, according to Moderna. This development opens a path for a new vaccination option aimed at individuals aged 50 and above, targeting protection against influenza.
Moderna revealed that the newly approved vaccine will likely become available at select retailers in the upcoming weeks. This announcement follows discussions and controversies, including skepticism from Robert F. Kennedy Jr. regarding mRNA technology.
A photograph from 2024 shows a researcher working at Moderna’s headquarters in Cambridge, Massachusetts, illustrating the ongoing efforts in mRNA vaccine development.
Increased Funding Needed for Psychiatric Hospitals 
Trump Administration Distributes ACA Refund Checks 
Higher Consumption of Ultra-Processed Foods Linked to Increased Health Risks 
Understanding Inflammation: Myths and Facts 
Calm Parenting: Strategies to Manage Stress 
Trump’s Executive Order to Combat Mosquitoes and Ticks in D.C.